7 pm Monday 12 June on Zoom
It has been a new dawn in bespoke medical therapies for thyroid eye disease since the FDA approval of Teprotumumab in the USA.
BOPSS have assembled a panel of TED Trial Investigators and other experts who can share their experiences and perspectives, to encourage wider UK participation and increase patient access to these exciting new therapies in the blossoming trial landscape.
You need to be logged in and have registered for the webinar to see the feedback form. Once you have filled in the form you will be emailed a link to your CPD certificate in a few days.
Please enter your score for each session below.
1 = poor
2 = satisfactory
3 = good
4 = excellent